Search Results - Lehr, Thorsten
- Showing 1 - 5 results of 5
- 
            1Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controll... by Ruiz Seco, Maria Pilar (Author) , Paño Pardo, José Ramón (Author) , Schoergenhofer, Christian (Author) , Dings, Christiane (Author) , Lehr, Thorsten (Author) , Herth, Felix (Author) , Krendyukov, Andriy (Author) , Straub, Carola (Author) , Kappler, Martin (Author) , Jilma, Bernd (Author) , Fricke, Harald (Author) , Pardo, Julian (Author) , de Miguel, Diego (Author) , Thiemann, Meinolf (Author) , Bergmann, Michael (Author) , Walczak, Henning (Author) , Hoeger, Thomas (Author) ,Call Number: Loading…
 Located: Loading…
  Article (Journal) Online Resource Article (Journal) Online Resource
- 
            2A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug-drug interaction perpetrators by Marok, Fatima (Author) , Wojtyniak, Jan-Georg (Author) , Fuhr, Laura Maria (Author) , Selzer, Dominik (Author) , Schwab, Matthias (Author) , Weiß, Johanna (Author) , Haefeli, Walter E. (Author) , Lehr, Thorsten (Author) ,Call Number: Loading…
 Located: Loading…
  Article (Journal) Online Resource Article (Journal) Online Resource
- 
            3Does the circulating ketoconazole metabolite N-deacetyl ketoconazole contribute to the drug-drug interaction potential of the parent compound? by Weiß, Johanna (Author) , Foerster, Kathrin (Author) , Weber, Maria (Author) , Burhenne, Jürgen (Author) , Mikus, Gerd (Author) , Lehr, Thorsten (Author) , Haefeli, Walter E. (Author) ,Call Number: Loading…
 Located: Loading…
  Article (Journal) Online Resource Article (Journal) Online Resource
- 
            4A physiologically based pharmacokinetic model of voriconazole integrating time-dependent inhibition of CYP3A4, genetic polymorphisms of CYP2C19 and predictions of drug-drug interac... by Li, Xia (Author) , Frechen, Sebastian (Author) , Moj, Daniel (Author) , Lehr, Thorsten (Author) , Taubert, Max (Author) , Hsin, Chih-hsuan (Author) , Mikus, Gerd (Author) , Neuvonen, Pertti J. (Author) , Olkkola, Klaus T. (Author) , Saari, Teijo I. (Author) , Fuhr, Uwe (Author) ,Call Number: Loading…
 Located: Loading…
  Article (Journal) Online Resource Article (Journal) Online Resource
- 
            5A mechanistic, enantioselective, physiologically based pharmacokinetic model of verapamil and norverapamil, built and evaluated for drug-drug interaction studies by Hanke, Nina (Author) , Türk, Denise (Author) , Selzer, Dominik (Author) , Wiebe, Sabrina (Author) , Fernandez, Éric (Author) , Stopfer, Peter (Author) , Nock, Valerie Christine (Author) , Lehr, Thorsten (Author) ,Call Number: Loading…
 Located: Loading…
  Article (Journal) Online Resource Article (Journal) Online Resource
Search Tools:
Related Subjects
              cytochrome P450 3A4 (CYP3A4)
              physiologically based pharmacokinetic (PBPK) modeling
              Apoptosis
              Asunercept
              CD95L (FasL)
              COVID-19
              CYP
              Death ligand blockade
              Drug transporters
              Drug-drug interaction
              Ketoconazole
              Lymphocytopenia
              N-deacetyl ketoconazole
              P-glycoprotein (P-gp)
              P-glycoprotein (Pgp)
              Phase 2 clinical trial
              UPLC-MS/MS
              drug-drug interaction
              drug-drug interactions (DDIs)
              drug-food interaction
              ketoconazole
              mechanism-based inactivation (MBI)
              metabolites
              model-informed drug discovery and development (MID3)
              non-competitive inhibition
              norverapamil
              reversible inhibition
              verapamil